These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31437)

  • 1. GABA involvement in neuroleptic-induced catalepsy.
    Worms P; Willigens MT; Lloyd KG
    J Pharm Pharmacol; 1978 Nov; 30(11):716-8. PubMed ID: 31437
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of GABA-agonists and antagonists on neuroleptic-induced catalepsy in rats.
    Worms P; Lloyd KG
    Life Sci; 1978 Aug; 23(5):475-7. PubMed ID: 29189
    [No Abstract]   [Full Text] [Related]  

  • 3. Biphasic effects of direct, but not indirect, GABA mimetics and antagonists on haloperidol-induced catalepsy.
    Worms P; Lloyd KG
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Mar; 311(2):179-84. PubMed ID: 7189827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biphasic effect of direct GABA mimetic drugs on haloperidol-induced catalepsy [proceedings].
    Lloyd KG; Willigens MT; Worms P
    Br J Pharmacol; 1979 Nov; 67(3):442P-443P. PubMed ID: 574045
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of baclofen and aminoxyacetic acid on catalepsy in the rat.
    Sypniewska M
    Pol J Pharmacol Pharm; 1978; 30(4):441-9. PubMed ID: 33368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of TRH on the catalepsy induced by various neuroleptics].
    Alamo C; Vallejo M; Cuenca E
    Arch Farmacol Toxicol; 1982 Dec; 8(3):151-6. PubMed ID: 6134498
    [No Abstract]   [Full Text] [Related]  

  • 7. A role for 5-hydroxytryptamine in the GABA-mimetic potentiation of alpha-flupenthixol-induced catalepsy in the rat.
    Davies JA; Williams J
    Br J Pharmacol; 1983 Jan; 78(1):137-42. PubMed ID: 6681721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BL-1020: a novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia.
    Geffen Y; Nudelman A; Gil-Ad I; Rephaeli A; Huang M; Savitsky K; Klapper L; Winkler I; Meltzer HY; Weizman A
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):1-13. PubMed ID: 18757185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The action of DL-2,4-diaminobutyric acid on the cataleptogenic effects of pilocarpine and alpha-flupenthixol in rats.
    Williams J; Davies JA
    Psychopharmacology (Berl); 1979 Jun; 64(1):81-3. PubMed ID: 113836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance to catalepsy following chronic haloperidol is not associated with changes in GABA release in the globus pallidus.
    O'Connor WT; Osborne PG; Ungerstedt U
    Brain Res; 1998 Mar; 787(2):299-303. PubMed ID: 9518659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic neuroleptic therapy: tolerance and GABA systems.
    Lloyd KG; Shibuya M; Davidson L; Hornykiewicz O
    Adv Biochem Psychopharmacol; 1977; 16():409-15. PubMed ID: 18890
    [No Abstract]   [Full Text] [Related]  

  • 12. Sustained gamma-aminobutyric acid receptor stimulation and chronic neuroleptic effects.
    Lloyd KG; Worms P
    Adv Biochem Psychopharmacol; 1980; 24():253-8. PubMed ID: 6105780
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of risperidone on catalepsy and cerebral dopamine, serotonin and GABA metabolism in the rat: comparison with haloperidol].
    Kikumoto O; Okamoto Y; Hayakawa H; Yokota N; Kawai K; Motohashi N; Yamawaki S
    Yakubutsu Seishin Kodo; 1993 Feb; 13(1):39-42. PubMed ID: 7686319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics.
    Arnt J; Christensen AV
    Eur J Pharmacol; 1981 Jan; 69(1):107-11. PubMed ID: 6110555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of in vivo activity of putative GABA-like compounds [proceedings].
    Melville EM; Turnbull MJ; Wheeler H
    Br J Pharmacol; 1979 May; 66(1):123P-124P. PubMed ID: 572255
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists.
    Elliott PJ; Close SP; Walsh DM; Hayes AG; Marriott AS
    J Neural Transm Park Dis Dement Sect; 1990; 2(2):91-100. PubMed ID: 1977410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs.
    McMillen BA; Scott SM; Davanzo EA
    J Pharm Pharmacol; 1988 Dec; 40(12):885-7. PubMed ID: 2907585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Catalepsy in the rat after haloperidol and some new GABA-ergic agents].
    Vamvakidès A
    Agressologie; 1984 Oct; 25(9):1011-6. PubMed ID: 6542324
    [No Abstract]   [Full Text] [Related]  

  • 19. [Stress effect on haloperidol-induced catalepsy and its circadian rhythm in intact and ovariectomized female rats].
    Baturin VA; Manvelian ÉA; Bulgakova MD
    Eksp Klin Farmakol; 2012; 75(5):3-6. PubMed ID: 22834120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of different types of cortical lesions on drug-induced catalepsy in rats: a pharmacological analysis.
    Worms P; Willigens MT; Continsouza-Blanc D; Lloyd KG
    Eur J Pharmacol; 1985 Jul; 113(1):53-9. PubMed ID: 2864264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.